V2X, Inc.
For the period ended Oct 2, 2026. Filed Nov 2, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Oct 2, 2026 · Filed Nov 2, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Changes to Shareholders' Equity
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES TO SHAREHOLDERS' EQUITY (UNAUDITED)
| Common Stock Issued · Treasury Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Loss · Total Shareholders' Equity | ||||||||
|---|---|---|---|---|---|---|---|---|
| (In thousands) · Shares · Amount · Shares · Amount · Retained Earnings | ||||||||
| Balance at December 31, 2024 | 31,560 | $316 | — | $— | $769,719 | $265,535 | $(9,418) | $1,026,152 |
| Net income | — | — | — | — | — | 8,107 | — | 8,107 |
| Foreign currency translation adjustments | — | — | — | — | — | — | 4,376 | 4,376 |
| Unrealized loss on cash flow hedge | — | — | — | — | — | — | (2,694) | (2,694) |
| Employee stock awards and stock options | 124 | 1 | — | — | 76 | — | — | 77 |
| Taxes withheld on stock compensation awards | — | — | — | — | (2,653) | — | — | (2,653) |
| Stock-based compensation | — | — | — | — | 2,452 | — | — | 2,452 |
| Balance at March 28, 2025 | 31,684 | $317 | — | $— | $769,594 | $273,642 | $(7,736) | $1,035,817 |
| Net income | — | — | — | — | — | 22,391 | — | 22,391 |
| Foreign currency translation adjustments | — | — | — | — | — | — | 5,404 | 5,404 |
| Unrealized loss on cash flow hedge | — | — | — | — | — | — | (1,277) | (1,277) |
| Employee stock awards and stock options | 25 | — | — | — | — | — | — | — |
| Taxes withheld on stock compensation awards | — | — | — | — | (321) | — | — | (321) |
| Stock-based compensation | — | — | — | — | 3,729 | — | — | 3,729 |
| Balance at June 27, 2025 | 31,709 | $317 | — | $— | $773,002 | $296,033 | $(3,609) | $1,065,743 |
| Net income | — | — | — | — | — | 24,605 | — | 24,605 |
| Foreign currency translation adjustments | — | — | — | — | — | — | (3,740) | (3,740) |
| Unrealized loss on cash flow hedge | — | — | — | — | — | — | (317) | (317) |
| Employee stock awards and stock options | 22 | — | — | — | 481 | — | — | 481 |
| Taxes withheld on stock compensation awards | — | — | — | — | (8) | — | — | (8) |
| Stock-based compensation | — | — | — | — | 2,940 | — | — | 2,940 |
| Treasury stock | — | — | (200) | (10,056) | — | — | — | (10,056) |
| Balance at September 26, 2025 | 31,731 | $317 | (200) | $(10,056) | $776,415 | $320,638 | $(7,666) | $1,079,648 |
| Common Stock Issued · Treasury Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Loss · Total Shareholders' Equity | ||||||||
|---|---|---|---|---|---|---|---|---|
| (In thousands) · Shares · Amount · Shares · Amount · Retained Earnings | ||||||||
| Balance at December 31, 2025 | 31,735 | $317 | (564) | $(30,274) | $779,084 | $343,417 | $(7,908) | $1,084,636 |
| Net income | — | — | — | — | — | 18,925 | — | 18,925 |
| Foreign currency translation adjustments | — | — | — | — | — | — | (657) | (657) |
| Unrealized gain on cash flow hedge | — | — | — | — | — | — | 1,728 | 1,728 |
| Employee stock awards and stock options | 139 | 1 | — | — | 59 | — | — | 60 |
| Taxes withheld on stock compensation awards | — | — | — | — | (4,758) | — | — | (4,758) |
| Stock-based compensation | — | — | — | — | 3,609 | — | — | 3,609 |
| Balance at April 3, 2026 | 31,874 | $318 | (564) | $(30,274) | $777,994 | $362,342 | $(6,837) | $1,103,543 |
| Net income | — | — | — | — | — | 25,540 | — | 25,540 |
| Foreign currency translation adjustments | — | — | — | — | — | — | 6 | 6 |
| Unrealized gain on cash flow hedge | — | — | — | — | — | — | 1,052 | 1,052 |
| Employee stock awards and stock options | 35 | 1 | — | — | 81 | — | — | 82 |
| Taxes withheld on stock compensation awards | — | — | — | — | (577) | — | — | (577) |
| Stock-based compensation | — | — | — | — | 4,810 | — | — | 4,810 |
| Balance at July 3, 2026 | 31,909 | $319 | (564) | $(30,274) | $782,308 | $387,882 | $(5,779) | $1,134,456 |
| Net income | — | — | — | — | — | 31,993 | — | 31,993 |
| Foreign currency translation adjustments | — | — | — | — | — | — | (400) | (400) |
| Unrealized gain on cash flow hedge | — | — | — | — | — | — | 1,409 | 1,409 |
| Employee stock awards and stock options | 3 | — | — | — | — | — | — | — |
| Taxes withheld on stock compensation awards | — | — | — | — | (82) | — | — | (82) |
| Stock-based compensation | — | — | — | — | 3,419 | — | — | 3,419 |
| Balance at October 2, 2026 | 31,912 | $319 | (564) | $(30,274) | $785,645 | $419,875 | $(4,770) | $1,170,795 |
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
NOTE 1
DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Business
V2X, Inc. is a leading provider of critical mission solutions primarily to defense customers globally. The Company operates asone segment and offers a broad suite of capabilities including multi-domain high impact readiness, integrated supply chain management, assured communications, mission solutions, and platform renewal and modernization to national security, defense, civilian and international customers.
Unless the context otherwise requires or unless stated otherwise, references in these notes to "V2X," "we," "us," "our," "the Company" and "our Company" refer to V2X, Inc. and all of its consolidated subsidiaries, taken together as a whole.
Equity Investment
In 2011, the Company entered into a joint venture agreement with APTIM Federal Services LLC. Pursuant to the joint venture agreement, High Desert Support Services, LLC (HDSS) was established to pursue and perform work on the Ft. Irwin Installation Support Services Contract, which was awarded to HDSS in October 2012. In 2018, the Company entered into a joint venture agreement with J&J Maintenance, pursuant to which J&J Facilities Support, LLC (J&J) was established to pursue and perform work on various U.S. government contracts. In 2020, the Company entered into a joint venture agreement with Kuwait Resources House for Human Resources Management and Services Company, pursuant to which ServCore Resources and Services Solutions, LLC (ServCore) was established to operate and manage labor and life support services outside of the continental U.S. at designated locations serviced by V2X and others around the world. In February 2022, the Company and Permagreen Grønland formed Inuksuk A/S (Inuksuk), a corporation in Greenland, to bid for certain contracts in Greenland.
The Company accounts for its investments in HDSS, J&J, ServCore and Inuksuk under the equity method and has the ability to exercise significant influence over, but does not hold a controlling interest in, these entities. The Company's proportionate 25%,50%,40% and 49% shares, respectively, of income or losses from HDSS, J&J, ServCore and Inuksuk are recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Income. These investments are recorded in other non-current assets in the Condensed Consolidated Balance Sheets.
When cash distributions are received by the Company from its equity method investments, the cash distribution is compared to cumulative earnings and cumulative cash distributions. Cash distributions received are recorded as a return on investment in operating cash flows within the Condensed Consolidated Statements of Cash Flows to the extent cumulative cash distributions are less than cumulative earnings. Any cash distributions in excess of cumulative earnings are recorded as a return of investment in investing cash flows within the Condensed Consolidated Statements of Cash Flows. As of October 2, 2026, and December 31, 2025, the Company's combined investment balance was $12.6 million and $10.8 million, respectively, included in other non-current assets on the Company's Condensed Consolidated Balance Sheets. The Company's proportionate share of income from equity method investments was $1.3 million and $4.8 million for the three and nine months ended October 2, 2026, respectively, and $2.6 million and $5.5 million for the three and nine months ended September 26, 2025, respectively.
Basis of Presentation
The Company's quarterly financial periods end on the Friday closest to the last day of the calendar quarter (October 2, 2026, for the third quarter of 2026, and September 26, 2025, for the third quarter of 2025), except for the last quarter of the fiscal year, which ends on December 31. For ease of presentation, the quarterly financial statements included herein are described as three months ended.
The unaudited interim Condensed Consolidated Financial Statements of V2X have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). Accordingly, certain information and note disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the U.S. (GAAP) have been omitted. These unaudited interim Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2025.
It is management’s opinion that these financial statements include all normal and recurring adjustments necessary for a fair presentation of the Company’s financial position and operating results. Revenue and net income for any interim period are not necessarily indicative of future or annual results.
Certain prior year amounts have been reclassified to conform to the current year presentation. These reclassifications had no material impact on the results of operations, financial position, or changes in shareholders’ equity.
Restricted Cash
As of October 2, 2026, the Company had total cash, cash equivalents, and restricted cash of $265.1 million which included $4.0 million of restricted cash. The Company's restricted cash was $3.0 million as of December 31, 2025.
Cloud Computing Arrangements (CCA)
The Company capitalizes implementation costs associated with its CCA consistent with costs capitalized for internal-use software. Capitalized CCA implementation costs are included in prepaid expenses and other current assets and other non-current assets on the Company's Condensed Consolidated Balance Sheets. The CCA implementation costs are amortized over the term of the related hosting agreement, including renewal periods that are reasonably certain to be exercised. Amortization expense of CCA implementation costs is included in cost of revenue on the Company's Condensed Consolidated Statements of Income. The CCA implementation costs are included within operating activities on the Company's Condensed Consolidated Statements of Cash Flows.
As of October 2, 2026, and December 31, 2025, the Company had total capitalized CCA implementation costs, net of accumulated amortization, of $24.6 million and $25.1 million, respectively, included in prepaid expenses and other current assets, and other non-current assets on the Company's Condensed Consolidated Balance Sheets.
Prepaid Expenses and Other Current Assets
The components of prepaid expenses and other current assets are as follows:
| As of | ||
|---|---|---|
| October 2, | December 31, | |
| (In thousands) | 2026 | 2025 |
| Inventory, net | $62,744 | $45,854 |
| Prepaid expenses | 61,381 | 48,895 |
| Prepaid taxes | 3,196 | 9,427 |
| Other | 45,379 | 22,926 |
| Total | $172,700 | $127,102 |
NOTE 2
RECENT ACCOUNTING STANDARDS UPDATE
In November 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2024-03 Expense Disaggregation Disclosures (Subtopic 220-40), as amended by ASU No. 2025-01 Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date, to require public business entities (PBEs) to disclose disaggregated information about expenses to help investors better understand an entity's performance, better assess the entity's prospects for future cash flows, and compare an entity's performance over time and with that of other entities. The amendments in this ASU are effective for PBEs for annual reporting periods beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of adopting this standard on its consolidated financial statements.
In September 2025, the FASB issued ASU No. 2025-06 Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use-Software, to remove all references to prescriptive and sequential software development stages throughout Subtopic 350-40 to better align the accounting for software costs with how software is developed. The amendments in this ASU are effective for all entities for annual reporting periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods. Early adoption is permitted as of the beginning of an annual reporting period. The Company is currently evaluating the impact of adopting this standard on its consolidated financial statements.
NOTE 3
REVENUE
Remaining Performance Obligations
Remaining performance obligations represent firm orders by the customer and exclude potential orders under indefinite delivery and indefinite quantity (IDIQ) contracts, unexercised contract options and contracts awarded to us that are being protested by competitors with the U.S. Government Accountability Office (GAO) or in the U.S. Court of Federal Claims (COFC) for which a stop work order has been received by the Company. The level of order activity related to programs can be affected by the timing of government funding authorizations and their project evaluation cycles. Year-over-year comparisons could, at times, be impacted by these factors, among others.
The Company's contracts are multi-year contracts and typically include an initial period ofone year or less with annualone year (or less) option periods. The number of option periods varies by contract, and there is no guarantee that an option period will be exercised. The right to exercise an option period is at the sole discretion of the U.S. government when the Company is the prime contractor or of the prime contractor when the Company is a subcontractor. The Company expects to recognize a substantial portion of its performance obligations as revenue within the next 12 months. However, the U.S. government or the prime contractor may cancel any contract at any time through a termination for convenience, including by not exercising its renewal option, or for cause. Substantially all the Company's contracts have terms that would permit recovery of all or a portion of the Company's incurred costs and fees for work performed in the event of a termination for convenience.
Remaining performance obligations are presented in the following table:
| As of | ||
|---|---|---|
| October 2, | December 31, | |
| (In millions) | 2026 | 2025 |
| Performance Obligations | $3,871 | $3,375 |
As of October 2, 2026, the Company expects to recognize approximately 27% of the remaining performance obligations as revenue in 2026 and the majority of the remaining balance as revenue in 2027 and 2028.
Contract Estimates
The impact of adjustments in contract estimates on the Company's operating income can be reflected in either revenue or cost of revenue. Cumulative adjustments for the three and nine months ended October 2, 2026, decreased operating income by $1.1 million and $0.4 million, respectively. Cumulative adjustments for the three and nine months ended September 26, 2025, increased operating income by $2.5 million and $8.1 million, respectively.
For the three and nine months ended October 2, 2026, the net adjustments to operating income increased revenue by $0.3 million and $5.7 million, respectively. For the three and nine months ended September 26, 2025, the net adjustments to operating income increased revenue by $5.0 million and $24.7 million, respectively.
Revenue by Category
Generally, the sales price elements for the Company's contracts are cost-plus, cost-reimbursable, firm-fixed-price and time-and-materials, all of which are commonly identified with a single contract. On a cost-plus contract, the Company is paid allowable incurred costs plus a profit, which can be fixed or variable depending on the contract’s fee arrangement, up to funding levels predetermined by the Company's customers.
On cost-plus contracts, the Company does not bear the risks of unexpected cost overruns, provided that incurred costs do not exceed the predetermined funded amounts. Most of the Company's cost-plus contracts also contain a firm-fixed-price element. Cost-plus contracts with award and incentive fee provisions are primarily variable contract fee arrangements. Award fees provide for a fee based on actual performance relative to contractually specified performance criteria. Incentive fees are based on the relationship between total allowable and target cost. Most of the Company's contracts include a cost-reimbursable element to capture costs of consumable materials required for the program. Typically, these costs do not bear fees.
On a firm-fixed-price contract, the Company agrees to perform the contractual statement of work for a predetermined contract price. A firm-fixed-price contract typically offers higher profit margin potential than a cost-plus contract, which is commensurate with the greater levels of risk assumed on a firm-fixed-price contract. Although a firm-fixed-price contract generally permits retention of profits if the total actual contract costs are less than the estimated contract costs, the Company bears the risk that increased or unexpected costs may reduce profit or cause the Company to sustain losses on the contract. Although the overall scope of work required under the contract may not change, profit may be adjusted as experience is gained and as efficiencies are realized or unexpected costs are incurred.
On a time-and-materials contract, the Company is reimbursed for labor at fixed hourly rates and generally reimbursed separately for allowable materials, costs and expenses at cost. For this contract type, the Company bears the risk that labor costs and allocable indirect expenses are greater than the fixed hourly rate defined within the contract.
Revenue by contract type is as follows:
| Three Months Ended | Nine Months Ended | |||||
|---|---|---|---|---|---|---|
| October 2, | September 26, | % | October 2, | September 26, | % | |
| (In thousands) | 2026 | 2025 | Change | 2026 | 2025 | Change |
| Cost-plus and cost-reimbursable | $692,452 | $702,557 | (1.4)% | $2,180,075 | $1,973,210 | 10.5% |
| Firm-fixed-price | 419,111 | 436,528 | (4.0)% | 1,181,520 | 1,205,705 | (2.0)% |
| Time-and-materials | 159,900 | 28,052 | 470.0% | 420,639 | 82,475 | 410.0% |
| Total revenue | $1,271,463 | $1,167,137 | $3,782,234 | $3,261,390 | ||
Revenue by geographic region in which the contract is performed is as follows:
| Three Months Ended | Nine Months Ended | |||||
|---|---|---|---|---|---|---|
| October 2, | September 26, | % | October 2, | September 26, | % | |
| (In thousands) | 2026 | 2025 | Change | 2026 | 2025 | Change |
| United States | $894,067 | $684,659 | 30.6% | $2,502,133 | $1,894,474 | 32.1% |
| Middle East | 240,547 | 344,605 | (30.2)% | 879,430 | 983,267 | (10.6)% |
| Asia | 88,213 | 81,417 | 8.3% | 250,916 | 234,188 | 7.1% |
| Europe | 48,636 | 56,456 | (13.9)% | 149,755 | 149,461 | 0.2% |
| Total revenue | $1,271,463 | $1,167,137 | $3,782,234 | $3,261,390 | ||
Revenue by contract relationship is as follows:
| Three Months Ended | Nine Months Ended | |||||
|---|---|---|---|---|---|---|
| October 2, | September 26, | % | October 2, | September 26, | % | |
| (In thousands) | 2026 | 2025 | Change | 2026 | 2025 | Change |
| Prime contractor | $1,219,666 | $1,109,660 | 9.9% | $3,623,728 | $3,081,746 | 17.6% |
| Subcontractor | 51,797 | 57,477 | (9.9)% | 158,506 | 179,644 | (11.8)% |
| Total revenue | $1,271,463 | $1,167,137 | $3,782,234 | $3,261,390 | ||
Revenue by customer is as follows:
| Three Months Ended | Nine Months Ended | |||||
|---|---|---|---|---|---|---|
| October 2, | September 26, | % | October 2, | September 26, | % | |
| (In thousands) | 2026 | 2025 | Change | 2026 | 2025 | Change |
| Army | $337,688 | $449,031 | (24.8)% | $1,199,914 | $1,348,610 | (11.0)% |
| Navy | 389,726 | 390,542 | (0.2)% | 1,147,819 | 1,090,936 | 5.2% |
| Air Force | 251,275 | 167,571 | 50.0% | 634,298 | 374,519 | 69.4% |
| Other | 292,774 | 159,993 | 83.0% | 800,203 | 447,325 | 78.9% |
| Total revenue | $1,271,463 | $1,167,137 | $3,782,234 | $3,261,390 | ||
Contract Balances
The timing of revenue recognition, billings, and cash collections results in billed and unbilled accounts receivable (contract assets) and customer advances and deposits (contract liabilities) on the Condensed Consolidated Balance Sheets. Amounts are billed as work progresses in accordance with agreed-upon contractual terms at periodic intervals (e.g., biweekly or monthly). Generally, billing occurs subsequent to revenue recognition, resulting in contract assets. However, the Company may receive advances or deposits from its customers before revenue is recognized, resulting in contract liabilities. These advance billings and payments are not considered significant financing components because they are frequently intended to ensure that both parties are in conformance with the primary contract terms. These assets and liabilities are reported on the Condensed Consolidated Balance Sheets on a contract-by-contract basis at the end of each reporting period.
As of October 2, 2026, and December 31, 2025, the Company had contract assets of $649.4 million and $628.5 million, respectively. Contract assets primarily consist of unbilled receivables which represent rights to consideration for work completed but not billed as of the reporting date. The balance of unbilled receivables consists of costs and fees that are: (i) billable immediately; (ii) billable on contract completion; or (iii) billable upon other specified events, such as the resolution of a request for equitable adjustment. Refer to Note 4, Receivables for additional information regarding the composition of the Company's receivable balances. As of October 2, 2026, and December 31, 2025, contract liabilities, included in other accrued liabilities in the Condensed Consolidated Balance Sheets, were $134.7 million and $100.7 million, respectively. As of January 1, 2025, the Company had contract assets of $620.5 million and contract liabilities of $98.7 million.
NOTE 4
RECEIVABLES
Receivables were comprised of the following:
| As of | ||
|---|---|---|
| October 2, | December 31, | |
| (In thousands) | 2026 | 2025 |
| Billed receivables | $146,991 | $87,089 |
| Unbilled receivables (contract assets) | 649,423 | 628,529 |
| Other | 13,372 | 14,638 |
| Total receivables | $809,786 | $730,256 |
As of October 2, 2026, and December 31, 2025, substantially all billed receivables were due from the U.S. government, either directly as prime contractor to the U.S. government or as subcontractor to another prime contractor to the U.S. government. Because the Company's billed receivables are with the U.S. government, the Company does not believe it has a material credit risk exposure.
Unbilled receivables are contract assets that represent revenue recognized on long-term contracts in excess of amounts billed as of the balance sheet date. The Company expects to bill customers for most of its October 2, 2026, contract assets within the next 12 months. Changes in the balance of receivables are primarily due to the timing differences between the Company's performance and its customers' payments.
NOTE 5
DEBT
Senior Secured Credit Facilities
First Lien Credit Agreement
On May 29, 2026, the First Lien Credit Agreement was amended to provide, among other things, a new tranche of term loans in an aggregate original principal amount of $868.5 million (the New Term Loans), in which the New Term Loans replaced or refinanced in full all the existing term loans outstanding under the First Lien Term Tranche in effect immediately prior to the amendment (the Existing Term Loans). The loans under the First Lien Credit Agreement, as amended (the First Lien Credit Agreement), amortize in an amount equal to approximately $2.2 million per quarter through September 30, 2030, with the balance of $829.4 million due on December 6, 2030. The replacement of the Existing Term Loans with the New Term Loans resulted in a loss on extinguishment of debt of $1.7 million in the Condensed Consolidated Statements of Income for the nine months ended October 2, 2026.
On January 2, 2025, the First Lien Credit Agreement was amended to provide, among other things, a new tranche of term loans to replace or refinance in full all the existing term loans outstanding under the First Lien Term Tranche, resulting in a loss on extinguishment of debt of $2.2 million in the Condensed Consolidated Statements of Income for the nine months ended September 26, 2025.
V2X LLC (V2X Borrower)'s obligations under the First Lien Credit Agreement are guaranteed by V2X Intermediate LLC and V2X Borrower’s wholly-owned domestic subsidiaries (collectively, the Guarantors), subject to customary exceptions and limitations. The V2X Borrower’s obligations under the First Lien Credit Agreement and the Guarantors’ obligations under the related guarantees are secured by a first priority lien on substantially all the V2X Borrower’s and the Guarantors’ assets which exists on a pari passu basis with the lien held by the 2023 Credit Agreement (as defined below) lenders.
The borrowings under the First Lien Credit Agreement bear interest at rates that, at the V2X Borrower’s option, can be either a base rate, determined by reference to the greater of (a) (i) the federal funds rate plus 0.50%, (ii) the prime lending rate, and (iii) an adjusted Secured Overnight Financing Rate (SOFR) rate plus 1.00%, plus a margin of 1.00% per annum, or (b) SOFR, plus a margin of 2.00% per annum. As of October 2, 2026, the effective interest rate for the First Lien Credit Agreement was 6.44%.
The First Lien Credit Agreement contains customary representations and warranties and affirmative covenants. The First Lien Credit Agreement also includes negative covenants that limit, among other things, the incurrence of additional indebtedness and additional liens, certain sales of assets, dividends, investments and advances, prepayments of debt and certain mergers and acquisitions.
The First Lien Credit Agreement contains customary events of default, including, but not limited to, payment defaults, material breaches of representations and warranties, covenant defaults, events of bankruptcy and insolvency, failure of any guaranty or security document supporting the First Lien Credit Agreement to be in full force and effect, and changes of control without lender consent. If an event of default occurs and is continuing, the V2X Borrower may be required immediately to repay all amounts outstanding under the First Lien Credit Agreement.
As of October 2, 2026, the carrying value of the First Lien Credit Agreement was $864.2 million, excluding deferred discount and unamortized deferred financing costs of $19.7 million. The estimated fair value of the First Lien Credit Agreement as of October 2, 2026, was $863.1 million. The fair value is based on observable inputs of interest rates that are currently available to us for debt with similar terms and maturities for non-public debt (Level 2).
2023 Credit Agreement
On February 28, 2023, the V2X Borrower entered into a credit agreement (the 2023 Credit Agreement) among the lenders identified therein and Bank of America, N.A., as administrative agent, collateral agent, swingline lender and letter of credit issuer. The 2023 Credit Agreement provides for $750.0 million in senior secured financing, with a first lien on substantially all the V2X Borrower’s assets and consists of (a) a $500.0 million five-year revolving credit facility (the 2023 Revolver) (which includes (i) a $50.0 million sublimit of availability for letters of credit, and (ii) a $50.0 million sublimit for short-term borrowings on a swingline basis) and (b) afive-year $250.0 million term loan (the 2023 Term Loan).
On March 31, 2025, the 2023 Credit Agreement was amended to provide, among other things, a new tranche of term loans in an aggregate original principal amount of $237.5 million (the 2025 Term Loans), which replaced or refinanced in full all the existing term loans outstanding under the 2023 Credit Agreement in effect immediately prior to the amendment. The 2023 Credit Agreement was further amended to provide a new tranche of revolving credit commitments in an aggregate original principal amount of $500.0 million (the 2025 Revolver), which replaced or refinanced in full all the existing revolving credit loans and commitments outstanding under the 2023 Revolver in effect immediately prior to the amendment. The 2025 Term Loans amortize at approximately $1.5 million per quarter for the fiscal quarters ending June 30, 2025 through March 31, 2027, increasing to $3.0 million per quarter for the fiscal quarters ending June 30, 2027, through December 31, 2029, with the balance of $173.0 million due on March 31, 2030. The amendment to the 2023 Credit Agreement resulted in a loss on extinguishment of debt of $0.3 million in the Condensed Consolidated Statements of Income for the nine months ended September 26, 2025.
The V2X Borrower’s obligations under the 2023 Credit Agreement are guaranteed by the Guarantors, subject to customary exceptions and limitations. The V2X Borrower’s obligations under the 2023 Credit Agreement and the Guarantors’ obligations under the related guarantees are secured by a first priority lien on substantially all of the V2X Borrower’s and the Guarantors’ assets (subject to customary exceptions and limitations) which exists on a pari passu basis with the lien held by the First Lien Credit Agreement lenders.
The borrowings under the 2023 Credit Agreement bear interest at rates that, at the V2X Borrower’s option, can be either a base rate, determined by reference to the greater of (a) (i) the federal funds rate plus 0.50%, (ii) the prime lending rate, and (iii) an adjusted SOFR rate plus 1.00%, plus a margin of 0.50% to 1.50% per annum, or (b) SOFR, plus a margin of 1.50% to 2.50% per annum, in each case, depending on the consolidated total net leverage ratio of the V2X Borrower and its subsidiaries. As of October 2, 2026, the effective interest rate for the 2025 Term Loans was 5.84%.
Unutilized commitments under the 2025 Revolver are subject to a per annum fee ranging from 0.25% to 0.375% depending on the consolidated total net leverage ratio of the V2X Borrower and its subsidiaries.
The V2X Borrower is also required to pay a letter of credit fronting fee to each letter of credit issuer equal to 0.125% per annum of the amount available to be drawn under each such letter of credit (or such other amount as may be mutually agreed by the V2X Borrower and the applicable letter of credit issuer), as well as a fee to all lenders equal to the applicable margin to SOFR of revolving credit loans times the average daily amount available to be drawn under all outstanding letters of credit.
The 2023 Credit Agreement contains customary representations and warranties, which must be accurate for the V2X Borrower to borrow under the 2023 Credit Agreement, and affirmative covenants. The 2023 Credit Agreement also includes customary negative covenants that limit, among other things, the incurrence of additional indebtedness, and additional liens, transactions with affiliates, sales of assets, dividends, investments and advances, prepayments of debt, and certain mergers and acquisitions.
The 2023 Credit Agreement contains financial covenants requiring (a) the consolidated total net leverage ratio not to exceed 4.75 to 1.00 for the reporting periods ending on or prior to December 31, 2026, with further step downs thereafter, and (b) the consolidated interest coverage ratio be at least 2.00 to 1.00, which commenced with the reporting period ended on June 30, 2023.
The 2023 Credit Agreement contains customary events of default, including, but not limited to, payment defaults, material breaches of representations and warranties, covenant defaults, events of bankruptcy and insolvency, failure of any guaranty or security document supporting the 2023 Credit Agreement to be in full force and effect, and changes of control without the lender's consent. If an event of default occurs and is continuing, the V2X Borrower may be required immediately to repay all amounts outstanding under the 2023 Credit Agreement.
As of October 2, 2026, there wereno outstanding borrowings and $15.3 million of outstanding letters of credit under the 2025 Revolver. The Company had available borrowing capacity under the 2025 Revolver of $484.7 million as of October 2, 2026. Unamortized deferred financing costs related to the 2025 Revolver of $3.3 million are included in other non-current assets in the Condensed Consolidated Balance Sheets. As of October 2, 2026, the fair value of the 2025 Revolver approximated the carrying value because the debt bears a floating interest rate.
As of October 2, 2026, the carrying value of the 2025 Term Loans was $208.6 million, excluding unamortized deferred financing costs of $1.4 million. The estimated fair value of the 2025 Term Loans as of October 2, 2026, was $208.9 million. The fair value is based on observable inputs of interest rates that are currently available to us for debt with similar terms and maturities for non-public debt (Level 2).
The aggregate scheduled maturities under the First Lien Credit Agreement and 2023 Credit Agreement as of October 2, 2026, are as follows:
| (In thousands) | Payments due |
|---|---|
| 2026 (remainder of the year) | $3,656 |
| 2027 | 19,076 |
| 2028 | 20,560 |
| 2029 | 20,560 |
| 2030 | 1,008,922 |
| Total | $1,072,774 |
As of October 2, 2026, the Company was in compliance with all covenants related to the First Lien Credit Agreement and the 2023 Credit Agreement.
NOTE 6
DERIVATIVE INSTRUMENTS
During the periods covered by this report, the Company has made no changes to its policies or strategies for the use of derivative instruments and there has been no change in related accounting methods. For the Company's derivative instruments, which are designated as cash flow hedges, gains and losses are initially reported as a component of accumulated other comprehensive loss and subsequently recognized in earnings with the corresponding hedged item.
Interest Rate Derivative Instruments
As of October 2, 2026, the Company held $350.0 million of interest rate swap contracts to mitigate risks to earnings and cash flows relating to fluctuations in interest rates. During the nine months ended October 2, 2026, the Company elected not to renew certain interest rate swap contracts, which resulted in a decrease in interest rate swap contracts of $100.0 million from December 31, 2025. As of October 2, 2026, and December 31, 2025, these contracts had notional values of $318.8 million and $428.1 million, respectively. These contracts are designated and qualify as effective cash flow hedges.
The following table summarizes the amount at fair value and location of the derivative instruments for interest rate hedges in the Condensed Consolidated Balance Sheets:
| Fair Value (level 2) | |||
|---|---|---|---|
| As of | |||
| October 2, · December 31, | |||
| (In thousands) | Balance sheet caption | 2026 | 2025 |
| Interest rate swap designated as cash flow hedge | Prepaid expenses and other current assets | $2,330 | $— |
| Interest rate swap designated as cash flow hedge | Other non-current assets | $968 | $— |
| Interest rate swap designated as cash flow hedge | Other accrued liabilities | $— | $770 |
| Interest rate swap designated as cash flow hedge | Other non-current liabilities | $— | $1,380 |
| Interest rate swap designated as cash flow hedge | Accumulated other comprehensive loss | $3,298 | $(2,150) |
The Company regularly assesses the creditworthiness of the counterparty to its interest rate swaps. As of October 2, 2026, the counterparty to the interest rate swaps had performed in accordance with its contractual obligations. Both the counterparty credit risk and the Company's credit risk were considered in the fair value determination as of October 2, 2026.
Net interest rate derivative gains of $0.1 million were recognized in interest expense, net in the Condensed Consolidated Statements of Income for the three months ended October 2, 2026. Net interest rate derivative expenses of $2.8 million were recognized in interest expense, net, in the Condensed Consolidated Statements of Income for the nine months ended October 2, 2026. Net interest rate derivative gains of $0.7 million and $2.2 million were recognized in interest expense, net, in the Condensed Consolidated Statements of Income for the three and nine months ended September 26, 2025, respectively. The Company expects $2.4 million of existing interest rate swap gains reported in accumulated other comprehensive loss as of October 2, 2026, to be recognized in earnings within the next 12 months.
NOTE 7
COMMITMENTS AND CONTINGENCIES
General
From time to time, the Company is involved in various investigations, lawsuits, arbitrations, claims, enforcement actions and other legal proceedings, including government investigations and claims, which are incidental to the operation of its business. Some of these proceedings seek remedies relating to employment matters, matters relating to injuries to people or property damage, matters in connection with the Company's contracts and matters arising under laws relating to the protection of the environment. Additionally, U.S. government customers periodically advise the Company of claims and penalties concerning certain potential disallowed costs. When such findings are presented, V2X and the U.S. government representatives engage in discussions to enable V2X to evaluate the merits of these claims as well as to assess the amounts being claimed.
Where appropriate, provisions are made to reflect probable losses related to the matters raised by U.S. government representatives. Such assessments, along with any assessments regarding provisions for other legal proceedings, are reviewed on a quarterly basis for sufficiency based on the latest information available to us.
The Company estimated and accrued $16.5 million and $14.4 million as of October 2, 2026, and December 31, 2025, respectively, in other accrued liabilities in the Condensed Consolidated Balance Sheets for legal proceedings and for claims with respect to its U.S. government contracts as discussed below, including years where the U.S. government has not completed its incurred cost audits. Although the ultimate outcome of any legal matter or claim cannot be predicted with certainty, based on present information, including the assessment of the merits of a particular claim, the Company does not expect that any asserted or unasserted legal or contractual claims or proceedings, individually or in the aggregate, will have a material adverse effect on its cash flows, results of operations or financial condition.
U.S. Government Contracts, Investigations and Claims
The Company has U.S. government contracts that are funded incrementally on a year-to-year basis. Changes in government policies, priorities or funding levels through agency or program budget reductions by the U.S. Congress or executive agencies could have a material adverse effect on the Company's financial condition or results of operations. Furthermore, the Company's contracts with the U.S. government may be terminated or suspended by the U.S. government at any time, with or without cause. Such contract suspensions or terminations could result in non-reimbursable expenses or charges or otherwise adversely affect the Company's financial condition and results of operations.
Departments and agencies of the U.S. government have the authority to investigate various transactions and operations of the Company, and the results of such investigations may lead to administrative, civil or criminal proceedings, the ultimate outcome of which could be fines, penalties, repayments or compensatory or treble damages. U.S. government regulations provide that certain findings against a contractor may lead to suspension or debarment from future U.S. government contracts or the loss of export privileges for a company or an operating division or subdivision. Suspension or debarment could have a material adverse effect on the Company because of its reliance on U.S. government contracts.
U.S. government agencies, including the Defense Contract Audit Agency, the Defense Contract Management Agency and others, routinely audit and review the Company's performance on government contracts, indirect rates and pricing practices, and compliance with applicable contracting and procurement laws, regulations and standards. Accordingly, costs billed or billable to U.S. government customers are subject to potential adjustment upon audit by such agencies. The U.S. government agencies also review the adequacy of compliance with government standards for business systems, including accounting, earned value management, estimating, materials management and accounting, purchasing, and property management systems. A finding by a U.S. government agency that the Company’s business systems are not adequate could adversely affect the Company’s financial condition and results of operations.
In the performance of its contracts, the Company routinely requests contract modifications that require additional funding from U.S. government customers. Most often, these requests are due to customer-directed changes in the scope of work. While the Company is entitled to recovery of these costs under its contracts, the administrative process with the U.S. government customer may be protracted. Based on the circumstances, the Company periodically files requests for equitable adjustments (REAs) that are sometimes converted into claims. In some cases, these requests are disputed by the U.S. government customer. The Company believes its outstanding modifications, REAs and other claims will be resolved without material adverse impact to its results of operations, financial condition or cash flows.
NOTE 8
STOCK-BASED COMPENSATION
The Company maintains an equity incentive plan, the Third Amendment and Restatement of the V2X, Inc. 2014 Omnibus Incentive Plan, as amended and restated effective as of May 8, 2025 (the 2014 Omnibus Plan), to govern awards granted to V2X employees and directors, including nonqualified stock options (NQOs), restricted stock units (RSUs), performance share units (PSUs) and other awards. The Company accounts for NQOs, stock-settled RSUs and PSUs as equity-based compensation awards.
Stock-based compensation expense and the associated tax benefits impacting the Company's Condensed Consolidated Statements of Income were as follows:
| Three Months Ended | Nine Months Ended | |||
|---|---|---|---|---|
| October 2, | September 26, | October 2, | September 26, | |
| (In thousands) | 2026 | 2025 | 2026 | 2025 |
| Compensation costs for equity-based awards, pre-tax | $3,419 | $2,940 | $11,838 | $9,121 |
| Future tax benefit | $791 | $714 | $2,737 | $2,216 |
As of October 2, 2026, total unrecognized compensation costs related to equity-based awards were $25.2 million, which are expected to be recognized ratably over a weighted average period of 1.5 years.
The following table provides a summary of the activities for NQOs, RSUs and PSUs for the nine months ended October 2, 2026:
| NQOs · RSUs · PSUs | ||||||
|---|---|---|---|---|---|---|
| (In thousands, except per share data) | Shares | Weighted Average Exercise Price Per Share | Shares | Weighted Average Grant Date Fair Value Per Share | Shares | Weighted Average Grant Date Fair Value Per Share |
| Outstanding at January 1, 2026 | 10 | $21.19 | 408 | $46.96 | 368 | $48.48 |
| Granted | — | — | 190 | $70.57 | 120 | $76.46 |
| Exercised | (7) | $20.78 | — | — | — | — |
| Vested | — | — | (212) | $45.95 | (34) | $40.96 |
| Cancelled | — | — | — | — | (109) | $43.85 |
| Forfeited or expired | — | — | (32) | $57.74 | (40) | $62.28 |
| Outstanding at October 2, 2026 | 3 | $21.98 | 354 | $59.27 | 305 | $61.57 |
Restricted Stock Units
RSUs awarded to employees vest in one-third increments on each of the three anniversary dates following the grant date subject to continued employment as described in the RSU award agreement. RSUs issued to directors are typically granted annually and vest approximatelyone year after the grant date. The fair value of each RSU grant was determined based on the closing price of V2X common stock on the date of grant. Stock compensation expense will be recognized ratably over the requisite service period of the RSU awards.
As of October 2, 2026, there was $13.3 million of unrecognized RSU related compensation expense.
Performance Share Units
During the nine months ended October 2, 2026, the Company granted PSUs that become eligible to vest based on the achievement of Adjusted Earnings Per Share (adjusted EPS) and relative Total Shareholder Return (rTSR) goals over thethree-year performance period. The performance-based awards will vest and the stock will be issued at the end of athree-year period based on i) Company performance against an annual adjusted EPS target established each year, over three years, as determined by the Compensation and Human Capital Committee of the Company’s Board of Directors (Compensation Committee), and athree-year rTSR modifier as compared to certain Aerospace & Defense companies approved by the Compensation Committee and assuming ii) the employee’s continued service through the vesting date in accordance with the terms of the 2014 Omnibus Plan. The number of shares ultimately awarded, if any, can range up to 200% of the specified target awards. A Monte Carlo valuation model was used to determine the fair value of the awards by simulating 50,000 potential Total Shareholder Return outcomes for the Company and a group of peer companies over the performance periods to determine the amount of the payout that would occur in each simulation. The fair value is based on the average of the results.
As of October 2, 2026, there was $11.9 million of unrecognized PSU related compensation expense.
NOTE 9
INCOME TAXES
Effective Tax Rate
Income tax expense during interim periods is based on an estimated annual effective income tax rate, plus discrete items that may occur in any given interim period. The computation of the estimated effective income tax rate at each interim period requires certain estimates and judgment including, but not limited to, forecasted operating income for the year, projections of the income earned and taxed in various jurisdictions, newly enacted tax rate and legislative changes, permanent and temporary differences, and the likelihood of recovering deferred tax assets generated in the current year.
For the three months ended October 2, 2026, and September 26, 2025, the Company recorded income tax expense of $9.5 million and $8.1 million, respectively, representing effective income tax rates of 22.9% and 24.9%, respectively. For the nine months ended October 2, 2026, and September 26, 2025, the Company recorded income tax expense of $21.8 million and $17.2 million, respectively, representing effective income tax rates of 22.2% and 23.7%, respectively. The effective income tax rates vary from the federal statutory rate of 21.0% mainly due to state and foreign taxes, Net Controlled Foreign Corporation Tested Income (NCTI), disallowed compensation deduction under Internal Revenue Code Section 162(m), offset by foreign derived intangible income deduction, available deductions not included in book income and income tax credits.
Uncertain Tax Positions
As of both October 2, 2026, and December 31, 2025, unrecognized tax benefits from uncertain tax positions were $1.2 million.
Other
The One Big Beautiful Bill Act (OBBBA) was enacted on July 4, 2025. The OBBBA makes permanent key elements of the Tax Cuts and Jobs Act, including 100% bonus depreciation, domestic research expensing and increases the business interest expense limitation. The legislation has multiple effective dates, with certain provisions effective in 2025 and others implemented through 2027. The OBBBA did not significantly impact our income tax expense or effective tax rate for the three and nine months ended October 2, 2026.
NOTE 10
EARNINGS PER SHARE
Basic earnings per share (EPS) is computed by dividing net income, or loss, by the weighted average number of common shares outstanding for the period. Diluted EPS reflects potential dilution that could occur if securities to issue common stock were exercised or converted into common stock. Diluted EPS includes the dilutive effect of stock-based compensation outstanding after application of the treasury stock method.
| Three Months Ended | Nine Months Ended | |||
|---|---|---|---|---|
| October 2, | September 26, | October 2, | September 26, | |
| (In thousands, except per share data) | 2026 | 2025 | 2026 | 2025 |
| Net income | $31,993 | $24,605 | $76,458 | $55,103 |
| Weighted average common shares outstanding | 31,346 | 31,617 | 31,295 | 31,634 |
| Add: Dilutive impact of stock options | 3 | 12 | 4 | 16 |
| Add: Dilutive impact of restricted stock units and performance share units | 239 | 227 | 264 | 231 |
| Diluted weighted average common shares outstanding | 31,588 | 31,856 | 31,563 | 31,881 |
| Earnings per share | ||||
| Basic | $1.02 | $0.78 | $2.44 | $1.74 |
| Diluted | $1.01 | $0.77 | $2.42 | $1.73 |
The following table summarizes the weighted average of anti-dilutive securities excluded from the diluted EPS calculation.
| Three Months Ended | Nine Months Ended | |||
|---|---|---|---|---|
| October 2, | September 26, | October 2, | September 26, | |
| (In thousands) | 2026 | 2025 | 2026 | 2025 |
| Anti-dilutive restricted stock units and performance share units | — | 2 | 73 | 47 |
| Total | — | 2 | 73 | 47 |
NOTE 11
POST-EMPLOYMENT BENEFIT PLANS
Deferred Employee Compensation
The Company sponsors non-qualified deferred compensation plans, under which participants are eligible to defer a portion of their compensation on a tax-deferred basis. The assets in the plan are held in a Rabbi trust. Plan investments and obligations were recorded in other non-current assets and other non-current liabilities, respectively, in the Condensed Consolidated Balance Sheets, representing the fair value related to the deferred compensation plans. Adjustments to the fair value of plan investments and obligations are recorded in selling, general, and administrative expenses. The plan assets and liabilities were $6.2 million and $5.8 million as of October 2, 2026, and December 31, 2025, respectively.
Multi-Employer Pension Plans
Certain Company employees who perform work on contracts within the continental United States participate in multi-employer pension plans of which the Company is not the sponsor. Company expenses related to these plans were $5.3 million and $15.2 million for the three and nine months ended October 2, 2026, respectively, and $4.8 million and $13.7 million for the three and nine months ended September 26, 2025, respectively.
NOTE 12
SALE OF RECEIVABLES
The Company has a Master Accounts Receivable Purchase Agreement (MARPA Facility) with MUFG Bank, Ltd. (MUFG) for the sale of certain designated eligible receivables up to a maximum amount of $400.0 million with the U.S. government. Receivables sold under the MARPA Facility are without recourse for any U.S. government credit risk.
The Company accounts for these receivable transfers under the MARPA Facility as sales under ASC Topic 860, Transfers and Servicing, and removes the sold receivables from its balance sheet. The fair value of the sold receivables approximated their book value due to their short-term nature.
| As of and for the | ||
|---|---|---|
| Nine Months Ended | ||
| October 2, | September 26, | |
| (In thousands) | 2026 | 2025 |
| Beginning balance: | $276,720 | $218,897 |
| Sale of receivables | 3,156,997 | 2,610,710 |
| Cash collections | (3,289,991) | (2,593,745) |
| Outstanding balance sold to MUFG1 | 143,726 | 235,862 |
| Cash collected, not remitted to MUFG2 | (35,209) | (45,876) |
| Remaining sold receivables | $108,517 | $189,986 |
| 1 For the nine months ended October 2, 2026, the Company recorded a net cash outflow, excluding fees, from sale of receivables of $133.0 million from operating activities. | ||
| 2 Includes the cash collected on behalf of, but not yet remitted to, MUFG as of October 2, 2026. This balance is included in other accrued liabilities as of the balance sheet date. | ||
During the three months ended October 2, 2026, and September 26, 2025, the Company incurred purchase discount fees, net of servicing fees, of $2.4 million and $3.0 million, respectively, which are presented in other expense, net on the Condensed Consolidated Statements of Income. During the nine months ended October 2, 2026, and September 26, 2025, the Company incurred purchase discount fees, net of servicing fees, of $7.0 million and $8.1 million, respectively, which are presented in other expense, net on the Condensed Consolidated Statements of Income and are reflected as cash flows from operating activities on the Condensed Consolidated Statements of Cash Flows.
The Company does not retain an ongoing financial interest in the transferred receivables other than cash collection and administrative services. The Company estimated that its servicing fee was at fair value and therefore has not recognized a servicing asset or liability as of October 2, 2026. Proceeds from the sale of receivables are reflected as cash inflows from operating activities on the Condensed Consolidated Statements of Cash Flows.
NOTE 13
SEGMENT INFORMATION
The Company operates as a single reportable segment. V2X performs services worldwide, with the substantial majority of revenue derived from the U.S. government. The chief operating decision maker (CODM) for the Company is the President and Chief Executive Officer. The CODM uses consolidated profit metrics, including net income and operating income, as reported on the Condensed Consolidated Statements of Income, to allocate resources and assess financial performance.
Our CODM reviews significant expenses as reported in the Condensed Consolidated Statements of Income in addition to depreciation and amortization information, which is summarized below for the three and nine months ended October 2, 2026, and September 26, 2025:
| Three Months Ended | Nine Months Ended | |||
|---|---|---|---|---|
| October 2, | September 26, | October 2, | September 26, | |
| (In thousands) | 2026 | 2025 | 2026 | 2025 |
| Depreciation and amortization | $27,879 | $28,117 | $84,273 | $83,870 |
The CODM also reviews consolidated capital expenditures as reported as purchases of capital assets in the Condensed Consolidated Statements of Cash Flows.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.